Manufacturer of dental implants and biomaterials expands product registration with clinivation’s worldwide Approvals solution.
Natick, MA, October 25, 2007 – clinivation, Inc. announced today that Bionnovation Biomedical has selected clinivation’s Approvals solution.
“Bionnovation is working to establish its international market leadership in dental implants with its current next-generation product technology,” said Joseph Kozikowski, M.D., clinivation’s President and Chief Executive Officer. “We are pleased that Bionnovation’s senior management has selected clinivation to help position their products for continued growth and expansion,” he continued.
Clinivation’s Approvals Practice delivers regulatory expertise, development strategy, and an outstanding track record.
About Bionnovation Biomedical
Bionnovation develops and manufactures biomaterials, implants, and prosthetic components for the dental industry. Bionnovation is headquartered in Sao Paulo, Brazil, and has 66 employees.
More information is available on the company website at www.bionnovation.com.br.
